Hcw Biologics (HCWB)Director bought ~$60K

~$60K

Approx. value · 2,308 sh @ $26.00

2,733

Holds after · shares reported

Traded

May 8, 2025

Filed

May 9, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 8, 2025 · this disclosureInsiderDirector purchased ~$60K of HCWB shares in the open market

What came next

1. May 8, 2025Insider · 5 peopleInsiders: 5 purchases (~$2.8M)
2. May 16, 2025Insider · 3 peopleInsiders: 3 purchases (~$170K)
3. Sep 2, 2025Company filing · Form 8-K · Material agreementSigned an important agreement

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Hcw Biologics

For Hcw Biologics, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HCWB page.

Other recent filings by Gary M Winer, Director

• SEC Form 4 at Hcw Biologics (HCWB)May 20, 2025

The full history of Gary M Winer, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Hcw Biologics

• SEC Form 4Jul 31, 2026
• SEC Form 4Jul 31, 2026
• SEC Form 4Jul 31, 2026
• SEC Form 4May 27, 2026
• SEC Form 4May 27, 2026
• SEC Form 4May 27, 2026

Everything OQRO holds on this company is on its HCWB page.